Short answer
PULSE BIOSCIENCES, INC. (PLSE) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). Up to $75 million ATM equity facility, enabling flexible capital raising through Nasdaq or other permitted markets.
PULSE BIOSCIENCES, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Up to $75 million ATM equity facility, enabling flexible capital raising through Nasdaq or other permitted markets
- No obligation to sell; dilution occurs only if Pulse Biosciences exercises the facility
- Mizuho commission capped at 3.0% of gross proceeds, plus specified expense reimbursements
- Proceeds could strengthen funding flexibility, but future issuances may pressure per-share value and shareholder ownership
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PULSE BIOSCIENCES, INC. 8-K filings
Get the next PLSE 8-K as it lands
Follow PLSE for push alerts, or ask the research agent what this filing means.